🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate if omalizumab is effective in decreasing mortality in severe ho...
Status
Unknown
Location
Niagara Health - St. Catharine's Sites
Start Date
2021-10-15
Trial ID
NCT04720612
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
Elevated levels of immunoglobuline E in blood are said to promote the occur...
Status
Completed
Location
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria.
Start Date
2001-10
Trial ID
NCT00822783
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of omalizumab,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202903
Treatments Being Tested
Aim: The aim of this study was to investigate the effect of subcutaneous in...
Status
Completed
Location
University of Health Sciences
Start Date
2018-06-05
Trial ID
NCT04210323
Treatments Being Tested
The study is designed to explore the mode of action for omalizumab therapy ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01599637
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of omaliz...
Status
Completed
Location
Jonathan Corren MD, Inc.
Start Date
2017-11-15
Trial ID
NCT03280550
Treatments Being Tested
Pragmatic trial to define the magnitude and the predictive factors of the r...
Status
Unknown
Location
Universitair Ziekenhuis Brussel
Start Date
2019-05-10
Trial ID
NCT03476109
Treatments Being Tested
The study is a global Phase III, multicenter, randomized, double-blind, pla...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01264939